{"id":"F2007B01112","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 16 of 1994)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-1994","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":67885,"registerId":"commonwealth-F2007B01112-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 16 of 1994)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 16 of 1994\n\nI, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Human Services and Health and Delegate of the Minister for Human Services and Health, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1. This Declaration shall come into operation on 12 October 1994.\n\n2. Phenindione shall cease to be a drug or medicinal preparation to which Part VII of the National Health Act 1953 applies.\n\nDated this sixth day of October 1994.\n\nD. GRAHAM\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Human Services and Health\n\nDelegate of the Minister for Human Services and Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1335},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This instrument performs exactly the limited administrative function described in the title: removing Phenindione from PBS coverage. There is no evidence of scope creep or expansion beyond the original intent to delist this specific drug."},"complexity_factors":["Very short instrument with only 2 operative provisions","Single, clear administrative action (delisting one specific drug)","No defined terms, cross-references to other legislation, or conditional logic","Straightforward commencement date with no transitional provisions"],"plain_english_summary":"**What this does:** This document removes **Phenindione** (an anticoagulant or blood-thinning medication) from Australia's Pharmaceutical Benefits Scheme (PBS).\n\n**Who it affects:**\n- **Patients** who were prescribed Phenindione — they will now pay the full commercial price instead of the government-subsidised rate.\n- **Doctors and pharmacists** who can no longer prescribe or dispense this drug under the PBS.\n\n**Why it matters:** The PBS makes medicines affordable by having the government pay most of the cost. When a drug is \"delisted\" like this, it becomes significantly more expensive for patients. The decision was made after advice from the Pharmaceutical Benefits Advisory Committee (the expert body that reviews which drugs should be subsidised).\n\n**When it took effect:** 12 October 1994."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-1994","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-1994/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-1994/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-1994/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-1994/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-1994/documents"}}